Preparation of meloxicam–β-cyclodextrin–polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability

References

• Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev 1999;36:125–141.
   PubMed Web of Science ®Google Scholar
• Patil A, Pore Y, Kuchekar B. Effect of l-arginine on bicalutamide complexation with hydroxypropyl-β-cyclodextrin. Dig J Nanomat Bios 2008;3:89–98.
   Web of Science ®Google Scholar
• Muraa P, Bettinettib GP, Cirria M, Maestrellia F, Sorrentib M, Catenaccib L. Solid-state characterization and dissolution properties of naproxen–arginine–hydroxypropyl-β-cyclodextrin ternary system. Eur J Pharm Biopharm 2005;59:99–106.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017–1025.
   PubMed Web of Science ®Google Scholar
• Dutet J, Lahiani-Skiba M, Didier L, Jezequel S, Bounoure F, Barbot C et al. Nimesulide/cyclodextrin/PEG 6000 ternary complexes: physico-chemical characterization, dissolution studies and bioavailability in rats. J Incl Phenom Macrocycl Chem 2007;57:203–209.
   Web of Science ®Google Scholar
• Wulff M, Aldén M. Solid state studies of drug–cyclodextrin inclusion complexes in PEG 6000 prepared by a new method. Eur J Pharm Sci 1999;8:269–281.
   PubMed Web of Science ®Google Scholar
• Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions. Int J Pharm 1995;123:53–63.
   Web of Science ®Google Scholar
• Chaudhari P, Sharma P, Barhate N, Kulkarni P, Mistry C. Solubility enhancement of hydrophobic drug using synergistically interacting cyclodextrins and cosolvent. Curr Sci India 2007;92:1586–1591.
   Web of Science ®Google Scholar
• Faucci MT, Mura P. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins. Drug Dev Ind Pharm 2001;27:909–917.
   PubMed Web of Science ®Google Scholar
• Li P, Zhao L, Yalkowsky SH. Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs. J Pharm Sci 1999;88:1107–1111.
   PubMed Web of Science ®Google Scholar
• Jadhav GS, Vavia PR. Physicochemical, in silico and in vivo evaluation of a danazol–beta-cyclodextrin complex. Int J Pharm 2008;352:5–16.
   PubMed Web of Science ®Google Scholar
• Guerrero-Martínez A, Montoro T, Viñas MH, Tardajos G. Complexation and chiral drug recognition of an amphiphilic phenothiazine derivative with beta-cyclodextrin. J Pharm Sci 2008;97:1484–1498.
   PubMed Web of Science ®Google Scholar
• Franco C, Schwingel L, Lula I, Sinisterra RD, Koester LS, Bassani VL. Studies on coumestrol/beta-cyclodextrin association: inclusion complex characterization. Int J Pharm 2009;369:5–11.
   PubMed Web of Science ®Google Scholar
• Beloshe SP, Chougule DD, Shah RR, Ghodke SD, Pawar ND, Ghaste PR. Effect of method of preparation on pioglitazone HCl–β-cyclodextrin inclusion complexes. Asian J Pharmac 2010;4:168–172.
   Google Scholar
• Adhage NA, Vavia PR. β-Cyclodextrin inclusion complexation by milling. Pharm Pharmacol Com 2000;6:13–17.
   Google Scholar
• Lin SY, Hsu CH, Sheu MT. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process. J Pharm Biomed Anal 2010;53:799–803.
   PubMed Web of Science ®Google Scholar
• Singh R, Bharti N, Madan J, Hiremath SN. Characterization of cyclodextrin inclusion complexes—a review. J Pharm Sci Technol 2010;2:171–183.
   Google Scholar
• Davies NM, Skjodt NM. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug. Clin Pharmacokinet 1999;36:115–126.
   PubMed Web of Science ®Google Scholar
• Gallagher RM, Ball CP, Gatehouse PJ, Lobell M, Derrick PJ. Cyclodextrin–piroxicam inclusion complexes: analyses by mass spectrometry and molecular modeling. Int J Pharm 1997;165–166:523–531.
   Google Scholar
• Dalmora ME, Oliveira AG. Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in hexadecyltrimethylammonium bromide based microemulsion. Int J Pharm 1999;184:157–164.
   PubMed Web of Science ®Google Scholar
• Dalmora ME, Dalmora SL, Oliveira AG. Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect. Int J Pharm 2001;222:45–55.
   PubMed Web of Science ®Google Scholar
• Baboota S, Agarwal SP. Preparation and characterisation of meloxicam hydroxy propyl β-cyclodextrin inclusion complex. J Incl Phenom Macrocycl Chem 2005;51:219–224.
   Web of Science ®Google Scholar
• Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation. AAPS PharmSciTech 2004;5:e59.
   PubMed Web of Science ®Google Scholar
• Baboota S, Agarwal SP. Inclusion complexation of meloxicam with β-cyclodextrin. Ind J Pharm Sci 2002;64:408–411.
   Google Scholar
• Loftsson T. Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers. Pharmazie 1998;53:733–740.
   PubMed Web of Science ®Google Scholar
• Vijaya Kumar SG, Mishra DN. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000. Yakugaku Zasshi 2006;126:657–664.
   PubMed Web of Science ®Google Scholar
• Chowdary KP, Srinivas SV. Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl beta-cyclodextrin. AAPS PharmSciTech 2006;7:79.
   PubMed Web of Science ®Google Scholar
• Ribeiro L, Loftsson T, Ferreira D, Veiga F. Investigation and physicochemical characterization of vinpocetine–sulfobutyl ether beta-cyclodextrin binary and ternary complexes. Chem Pharm Bull 2003;51:914–922.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors KA. Phase solubility technique. Adv Anal Chem Instrum 1965;4:117–212.
   Google Scholar
• Valero M, Carrillo C. Effect of binary and ternary polyethyleneglycol and/or beta-cyclodextrin complexes on the photochemical and photosensitizing properties of naproxen. J Photochem Photobiol B, Biol 2004;74:151–160.
   PubMed Web of Science ®Google Scholar
• Aiman A, Obaidat AA, Ababneh NM. Improvement of glibenclamide bioavailability using cyclodextrin inclusion complex dispersed in polyethylene glycol. Jord J Pharm Sci 2009;2:119–130.
   Google Scholar
• Zutphen LF, Baumans V, Beynen AC. Principles of laboratory animal science, revised edition. A contribution to the humane use and care of animals and to the quality of experimental results. Utrecht: Elsevier Holland, 2001.
   Google Scholar
• Zutphen B. Education and training for the care and use of laboratory animals: an overview of current practices. Hilar J 2007;48:72–74.
   Google Scholar
• Nandi I, Bateson M, Bari M, Joshi HN. Synergistic effect of PEG-400 and cyclodextrin to enhance solubility of progesterone. AAPS PharmSciTech 2003;4:E1.
   Google Scholar
• Dollo G, Le Corre P, Chollet M, Chevanne F, Bertault M, Burgot JL et al. Improvement in solubility and dissolution rate of 1,2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. J Pharm Sci 1999;88:889–895.
   PubMed Web of Science ®Google Scholar